申请人:Hoechst Aktiengesellschaft
公开号:US05145867A1
公开(公告)日:1992-09-08
Naphthylalkylamino-substituted sulfamoylbenzoic acid derivatives, processes for the preparation thereof and the use thereof as medicines. Compounds I ##STR1## R(1) hydrogen, (C.sub.1 -C.sub.4)-alkyl and Na, K, NH.sub.4, Ca, Mg, R(2) and R(3) hydrogen, alkyl groups which can also be linked together in a ring, X oxygen, sulfur, SO, SO.sub.2, NR(6) [with R(6)=hydrogen-alkyl], CH.sub.2, CO, or a bond, R(4) phenyl, thienyl, which are unsubstituted or substituted R(5) hydrogen, (C.sub.1 -C.sub.4)-alkyl, n 1, 2, 3 or 4, where the naphthyl system is unsubstituted or substituted like the phenyl radical of R(4), and where X and R(4) together can also be Cl are medicaments for treating sickle-cell anemia.
萘基烷基
氨基磺酰基
苯甲酸衍
生物,其制备过程及作为药物的用途。化合物I:##STR1## R(1)氢,(C.sub.1-C.sub.4)-烷基和Na,K,NH.sub.4,Ca,Mg,R(2)和R(3)氢,烷基,也可以连接成环,X氧,
硫,SO,SO.sub.2,NR(6)[其中R(6)=氢-烷基],CH.sub.2,CO或键,R(4)苯基,
噻吩基,未取代或取代,R(5)氢,(C.sub.1-C.sub.4)-烷基,n 1、2、3或4,其中
萘基系统未取代或取代,如R(4)的苯基基团,X和R(4)还可以是Cl,用于治疗镰状细胞贫血的药物。